COVID-19 research
Gene: COPA
agree with green geneCreated: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
YES- this is covered on our targeted exomeCreated: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
Gene rating submitted by Kimberly Gilmour and Austen Worth on behalf of London North GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email 6th September the Specialist Test Group all agreed there is enough evidence to rate this gene Green.Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
Gene rating submitted by Tracy Briggs, David Gokhale and Abigal Rousseau on behalf of North West GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email on 20th June the Specialist Test Group all agreed there is enough evidence to rate this gene Green.Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
OriginaI Metadata from IUIS classification table (February, 2018) downloaded 20180614. IUIS Genetic defect (original gene symbol in IUIS download): COPA .PanelApp HGNC gene symbol check: COPA . IUIS Disease: COPA defect . IUIS Inheritance: AD .T cells: N/A, .B cells: N/A, .IUIS Other affected cells: PMN and tissue specific cells. IUIS Associated features: Autoimmune inflammatory arthritis and interstitial lung disease with Th17 dysregulation and autoantibody production. IUIS Major category: Autoinflammatory Disorders. IUIS Subcategory: Non-Inflammasome Related ConditionsCreated: 2 Jul 2018, 10:35 a.m.
Comment on list classification: changed rating from Amber to Green, there is enough evidence to support the role of COPA in immune dysfunctionCreated: 4 Jun 2018, 1:20 p.m.
added Jensson et al. (2017) PMID:29137621 describe an Icelandic family with three affected individuals over two generations with a rare clinical presentation of lung and joint disease and a histological diagnosis of follicular bronchiolitis. This is the second report of the p.Glu241Lys mutation in COPA, indicating the recurrent nature of the mutation. The mutation was reported to co-segregate with COPA syndrome in a large family from the USA with five affected members, and classified as pathogenic. The two separate occurrences of the p.Glu241Lys mutation in cases and its absence from a large number of sequenced genomes confirms its role in the pathogenesis of the COPA syndrome.Created: 4 Jun 2018, 1:18 p.m.
Comment on publications: added Noorelahi et al. (2018) PMID: 28956095 describe a 12-year-old boy presenting with dyspnea on exertion, fatigue and clubbing. Additional findings included a restrictive pattern of pulmonary involvement and positive inflammatory markers and autoantibodies. Genetic testing revealed a p.W240R variant of the COPA gene confirming the diagnosis of Copa syndrome.Created: 4 Jun 2018, 1:08 p.m.
added missense-tag. Currently only missense variants have been reportedCreated: 4 Jun 2018, 1:02 p.m.
Comment on publications: added publications to support COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis.Created: 4 Jun 2018, 12:59 p.m.
from Watkin et al. (2015) i PMID: 25894502 In 30 individuals from 5 unrelated families with Autoimmune interstitial lung, joint, and kidney disease identified 4 different heterozygous missense mutations in the COPA gene (601924.0001-601924.0004). All mutations affected the WD40 domain. Nine mutation carriers were clinically unaffected, consistent with incomplete penetrance. It has been indicated that the variants contribute to susceptibility susceptibility to infection.Created: 4 Jun 2018, 12:46 p.m.
COPA syndrome is an autoinflammatory disease that presents as pulmonary hemosiderosis and polyarticular arthritis. COPA gene encodes a subunit of the coatomer protein complex (COPI), a carrier complex required for retrograde protein trafficking from the Golgi to the endoplasmic reticulum (ER)Created: 4 Jun 2018, 11:24 a.m.
Comment on phenotypes: added MIMid from OMIM and phenotype from OrphanetCreated: 4 Jun 2018, 11:21 a.m.
This gene was absent from the original PanelApp PID panel dataset (review April 2018). However it was listed in external expert immunodeficiency diagnostic gene list(s) GOSH or GRID. In this combined PID panel, this gene has been rated as AMBER and needs further curational review to assess pertinence prior to v1.Created: 20 Apr 2018, 12:25 p.m.
Original metadata supplied by GRID. GRID Gene Symbol HGNC PanelApp check: COPA, GRID_Gene_Symbol: COPA, GRID_Transcript_ENS_Community submitted: ENST00000368069, GRID_Transcript_RefSeq: NM_001098398.1, GRID_Transcript_ENS_used_on_Production: ENST00000368069Created: 17 Apr 2018, 12:12 p.m.
gene: COPA was added gene: COPA was added to Viral susceptibility. Sources: Expert Review Green,Victorian Clinical Genetics Services,North West GLH,GRID V2.0,NHS GMS,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: COPA was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: COPA were set to 28956095; 25894502; 29137621 Phenotypes for gene: COPA were set to Autoimmune interstitial lung disease-arthritis syndrome; Autoimmune inflammatory arthritis and interstitial lung disease with Th17 dysregulation and autoantibody production; Autoinflammatory Disorders; Autoimmune inflammatoy arthritis and interstial lung disease, 616414; COPA syndrome